ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000230013.1	Tanespimycin	Chronic Lymphocytic Leukemia	0.030206682	Resistant
ENSG00000230013.1	Tanespimycin	Pancreatic adenocarcinoma	0.030289502	Sensitive